EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for XTLB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
December 31, 2024 -0.1169
September 30, 2024 -0.1765
June 30, 2024 -0.514
March 31, 2024 0.089
December 31, 2023 -0.052
September 30, 2023 -0.039
June 30, 2023 -0.067
March 31, 2023 -0.169
December 31, 2022 -0.137
September 30, 2022 -0.151
June 30, 2022 -0.052
March 31, 2022 0.013
December 31, 2021 0.396
September 30, 2021 -0.151
June 30, 2021 -0.218
March 31, 2021 0.054
December 31, 2020 -0.8428
September 30, 2020 -0.7215
June 30, 2020 -0.868
March 31, 2020 0.1362
December 31, 2019 -0.216
September 30, 2019 -0.244
June 30, 2019 -0.555
March 31, 2019 0.753
December 31, 2018 0.204
Date Value
September 30, 2018 0.20
June 30, 2018 0.007
March 31, 2018 0.17
December 31, 2017 -0.001
September 30, 2017 0.30
June 30, 2017 -0.30
March 31, 2017 -0.30
December 31, 2016 -0.40
September 30, 2016 -0.10
June 30, 2016 -0.20
March 31, 2016 -0.20
December 31, 2015 -0.90
September 30, 2015 -0.20
June 30, 2015 -0.20
March 31, 2015 -0.50
December 31, 2014 -0.40
September 30, 2014 -0.20
June 30, 2014 -0.20
March 31, 2014 -0.30
December 31, 2013 -0.50
September 30, 2013 0.20
June 30, 2013 -0.40
March 31, 2013 -0.40
December 31, 2012 -0.10
September 30, 2012 -0.022

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. -0.5804
Kamada Ltd. 0.1605
Can-Fite BioPharma Ltd. --
Galmed Pharmaceuticals Ltd. -2.318
Revium Recovery, Inc. -0.0096